The Impact of an Antibiotic (Cefazolin) Before Surgery on the Microbiome in Patients With Stage I-II Melanoma

Running, not enrolling · Phase 1

Conditions studied: Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma AJCC v8, Clinical Stage II Cutaneous Melanoma AJCC v8, Clinical Stage IIA Cutaneous Melanoma AJCC v8, Clinical Stage IIB Cutaneous Melanoma AJCC v8, Clinical Stage IIC Cutaneous Melanoma AJCC v8, Pathologic Stage I Cutaneous Melanoma AJCC v8, Pathologic Stage IA Cutaneous Melanoma AJCC v8, Pathologic Stage IB Cutaneous Melanoma AJCC v8, Pathologic Stage II Cutaneous Melanoma AJCC v8, Pathologic Stage IIA Cutaneous Melanoma AJCC v8, Pathologic Stage IIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIC Cutaneous Melanoma AJCC v8

In brief

This phase I trial investigates the impact of cefazolin before surgery on the microbiome in patients with stage I-II melanoma. Antibiotics, such as cefazolin, given at the time of surgery may cause a significant change in the microbes (like bacteria and viruses) found in the stomach and intestines. This trial may help researchers learn if any changes in microbes affect the body's ability to respond to surgery and cancer.

Key facts

Study ID

NCT04875728

Run by

M.D. Anderson Cancer Center

People needed

20

Starts

2020-09-08

Expected to finish

2027-02-02

Last updated by the study team

2026-05-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult subjects with early stage melanoma (stage I-II)
• Patients must be undergoing wide local excision +/- sentinel lymph node biopsy
• Patients must be capable of giving written informed consent, which includes compliance with the requirements and restrictions listed in the consent form

You may not qualify if…

• Use of antibiotics within the three months prior to surgery
• Allergy, sensitivity or anaphylaxis to beta-lactam or cephalosporin antibiotics
• Presence of an infection at the time of surgery
• Increased risk of infection due to a co-existing medical condition as determined by the surgical team or principal investigator (PI)
• Subjects with a condition requiring systemic treatment with either corticosteroids (> 10 mg daily prednisone equivalents) or other immunosuppressive medications within 14 days of study drug administration
• American Society of Anesthesiologists (ASA) grade > IV
• Refusal to participate in the study
• Patients who are pregnant will not be included in this study

Where it is running

• M D Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.